Romiplostim for SARS-CoV-2 Vaccine Induced Immune Thrombocytopenia

Am J Ther. 2021 Sep 9;28(6):e685-e687. doi: 10.1097/MJT.0000000000001447.
No abstract available

Publication types

  • Letter

MeSH terms

  • COVID-19 Vaccines
  • COVID-19*
  • Humans
  • Purpura, Thrombocytopenic, Idiopathic* / drug therapy
  • Receptors, Fc
  • Recombinant Fusion Proteins
  • SARS-CoV-2
  • Thrombopoietin

Substances

  • COVID-19 Vaccines
  • Receptors, Fc
  • Recombinant Fusion Proteins
  • Thrombopoietin
  • romiplostim